Jason Napodano
Jason Napodano
certainly education ideal positives study
The study certainly isn't ideal for Pfizer. There were some positives for Pfizer, and they will have to go out and do some education (on them).
bloated cost excellent good structure
I think Bristol-Myers is an excellent takeover candidate. It has a bloated cost structure and some really good mid- to late-stage products.
creates lose negative vibe
I think if they lose it really creates a negative vibe for the stock.
commercial seeing sleeping television watch
You are not going to be able to watch a television show without seeing a commercial for a sleeping pill.